» Articles » PMID: 32968689

Normal Respiratory Flora As a Cause of Community-Acquired Pneumonia

Overview
Date 2020 Sep 24
PMID 32968689
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Intensive studies have failed to identify an etiologic agent in >50% cases of community-acquired pneumonia (CAP). Bacterial pneumonia follows aspiration of recognized bacterial pathogens (RBPs) such as , , and after they have colonize the nasopharynx. We hypothesized that aspiration of normal respiratory flora (NRF) might also cause CAP.

Methods: We studied 120 patients hospitalized for CAP who provided a high-quality sputum specimen at, or soon after admission, using Gram stain, quantitative sputum culture, bacterial speciation by matrix-assisted laser desorption ionization time-of-flight, and viral polymerase chain reaction. Thresholds for diagnosis of bacterial infection were ≥10 colony-forming units (cfu)/mL sputum for RBPs and ≥10 cfu for NRF.

Results: Recognized bacterial pathogens were found in 68 of 120 (56.7%) patients; 14 (20.1%) of these had a coinfecting respiratory virus. Normal respiratory flora were found in 31 (25.8%) patients; 10 (32.2%) had a coinfecting respiratory virus. Infection by ≥2 RBPs occurred in 10 cases and by NRF together with RBPs in 13 cases. Among NRF, organisms identified as , which share many genetic features of , predominated. A respiratory virus alone was found in 16 of 120 (13.3%) patients. Overall, an etiologic diagnosis was established in 95.8% of cases.

Conclusions: Normal respiratory flora, with or without viral coinfection, appear to have caused one quarter of cases of CAP and may have played a contributory role in an additional 10.8% of cases caused by RBPs. An etiology for CAP was identified in >95% of patients who provided a high-quality sputum at, or soon after, the time of admission.

Citing Articles

Update on the evolving landscape of pneumococcal capsule types: new discoveries and way forward.

Ganaie F, Beall B, Yu J, van der Linden M, McGee L, Satzke C Clin Microbiol Rev. 2025; 38(1):e0017524.

PMID: 39878373 PMC: 11905375. DOI: 10.1128/cmr.00175-24.


Can clinical findings at admission allow withholding of antibiotics in patients hospitalized for community acquired pneumonia when a test for a respiratory virus is positive?.

Ward R, Gonzalez A, Kahla J, Musher D Pneumonia (Nathan). 2025; 17(1):1.

PMID: 39755704 PMC: 11700437. DOI: 10.1186/s41479-024-00153-9.


Respiratory tract bacteria distribution and transmission patterns among individuals in close contact.

Zhao N, Lian X, Du J, Ren H, Zhao T, Lu Q BMC Infect Dis. 2024; 24(1):1289.

PMID: 39538143 PMC: 11562301. DOI: 10.1186/s12879-024-10019-6.


Human metapneumovirus infection is associated with a substantial morbidity and mortality burden in adult inpatients.

Philippot Q, Rammaert B, Dauriat G, Daubin C, Schlemmer F, Costantini A Heliyon. 2024; 10(13):e33231.

PMID: 39035530 PMC: 11259828. DOI: 10.1016/j.heliyon.2024.e33231.


No evidence of difference in mortality with amoxicillin versus co-amoxiclav for hospital treatment of community-acquired pneumonia.

Wei J, Uppal A, Nganjimi C, Warr H, Ibrahim Y, Gu Q J Infect. 2024; 88(6):106161.

PMID: 38663754 PMC: 11893475. DOI: 10.1016/j.jinf.2024.106161.


References
1.
Jain S, Self W, Wunderink R, Fakhran S, Balk R, Bramley A . Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults. N Engl J Med. 2015; 373(5):415-27. PMC: 4728150. DOI: 10.1056/NEJMoa1500245. View

2.
Bartlett J, Finegold S . Anaerobic pleuropulmonary infections. Medicine (Baltimore). 1972; 51(6):413-50. DOI: 10.1097/00005792-197211000-00001. View

3.
Bartlett J . Diagnostic accuracy of transtracheal aspiration bacteriologic studies. Am Rev Respir Dis. 1977; 115(5):777-82. DOI: 10.1164/arrd.1977.115.5.777. View

4.
Shelburne S, Sahasrabhojane P, Saldana M, Yao H, Su X, Horstmann N . Streptococcus mitis strains causing severe clinical disease in cancer patients. Emerg Infect Dis. 2014; 20(5):762-71. PMC: 4012796. DOI: 10.3201/eid2005.130953. View

5.
File Jr T, Low D, Eckburg P, Talbot G, Friedland H, Lee J . Integrated analysis of FOCUS 1 and FOCUS 2: randomized, doubled-blinded, multicenter phase 3 trials of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in patients with community-acquired pneumonia. Clin Infect Dis. 2010; 51(12):1395-405. DOI: 10.1086/657313. View